Compounds like Peshawaraquinone (3), Lapachol (1), and Dehydro-α-lapachone (4) exhibited strong and selective inhibition of AChE, which is a hallmark of many current AD therapies. The gene discussed is ACHE; the disease is Alzheimer disease.